Download presentation
Presentation is loading. Please wait.
Published byДрагослав Росић Modified over 5 years ago
1
Drugs for Degenerative Diseases of the Nervous System
Chapter 20
2
Parkinson’s Disease Progressive loss of dopamine
Tremor, muscle rigidity Abnormal movement and posture Symptoms known as parkinsonism Tremors Muscle rigidity Bradykinesia Postural instability Affective flattening
3
Health Problems in Parkinsons’ Patients
Primarily affects muscle movement Patients often experience other health issues Anxiety, depression Sleep disturbances Dementia Autonomic nervous system disturbances
4
Parkinson's Gait before and after L-Dopa
6
Levodopa (Larodopa) Antiparkinson Agent; Dopaminergic Agent
Mechanism of action: restores dopamine within nerve terminals Primary use: to restore dopamine function or stimulate dopamine receptors within the brain
7
Benztropine Mesylate (Cogentin)
Antiparkinson Agent; Anticholinergic Agents Mechanism of action: block acetylcholine; inhibit over activity in brain Primary use: in early stages of disease
8
Alzheimer’s Disease Most common degenerative disease of CNS
Progressive loss of brain function Memory loss, confusion, dementia Cause unknown Possible causes Genetic defects Chronic inflammation Excess free radicals Environmental factors
9
Protein fragments in brain (normally broken down and excreted)
Twisted protein threads inside nerve cell. Tubules that transport nutrients and other important substances from one part of the nerve cell to another Plaque start to develop first in area of brain used for memory and cognitive functioning
10
Alzheimer’s Disease Structural Damage in Brain: Symptoms: Consists of
Amyloid plaques Neurofibrillary tangles Loss of connection between neurons Structural changes cause loss of neuron number and function Impaired memory and judgment Confusion and disorientation Inability to recognize family and friends Aggressive behavior Depression Psychoses, including paranoia and delusions Anxiety
11
Donepezil Hydrochloride (Aricept)
Alzheimer’s Disease Agent; Acetylcholinesterase (AChE) Inhibitors Mechanism of action: to prevent breakdown of acetylcholine; enhance transmission in neurons Primary use: slow progression of the disease
12
Drugs for Degenerative Diseases of the Nervous System
Goals Increased ease of movement Decrease in symptoms Understanding of drug regimen/disease Adherence to drug regimen Reporting of side effects
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.